Statistics on Biotechnology Use  
Results by fields of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

;Total Companies;Services;Industry and Construction;Agriculture;
No. of companies carrying out R&D in Biotechnology;1.198;760;358;80;
%Companies according to biotechnology used: Genetic code;33,3;42;15,5;30,8;
%Companies according to biotechnology used: Functional units;39,8;43,9;35,3;21,6;
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;24,2;28,2;15,1;26,7;
%Companies according to biotechnology used: Bioprocesses;49,6;39,7;75,1;30,3;
%Companies according to biotechnology used: Sub-cellular organisms;6,7;9,1;2,9;0;
%Companies according to biotechnology used: Bio-computing;23,9;32,4;8,9;9,8;
%Companies according to biotechnology used: Nanobiotechnology;11,2;14,3;6,3;2,8;
%Companies according to biotechnology used: Other;14,6;14,7;10,2;33,8;
Companies in which biotechnology activities are: Main and/or exclusive;644;522;102;19;
Companies in which biotechnology activities are: A secondary line of business;171;93;64;14;
Companies in which biotechnology activities are: A tool necessary for production;383;145;192;46;
%Company by field(s) of ultimate application of biotechnology use: Human Health;47,3;61,9;25,9;4,8;
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;19,4;21,2;12,8;31,6;
%Company by field(s) of ultimate application of biotechnology use: Food products;32,5;25,9;48,4;24,3;
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;24,1;22,6;18,8;63,1;
%Company by field(s) of ultimate application of biotechnology use: Environment;14,9;15,3;14,7;12,4;
%Company by field(s) of ultimate application of biotechnology use: Industry;12,8;14;12,3;3,8;
Personnel in R&D in biotechnology (no. of persons);13.615;8.885;3.811;919;
Personnel in R&D in biotechnology (no. of persons): Researchers;7.436;5.473;1.733;231;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;6.178;3.412;2.078;688;
Personnel in R&D in biotechnology (no. of persons): women;7.639;5.204;2.016;420;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;4.095;3.058;918;120;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;3.544;2.146;1.098;300;
Personnel in R&D in biotechnology (FTE);9.365,2;6.336,7;2.503,3;525,3;
Personnel in R&D in biotechnology (FTE): Researchers;5.410,6;4.035,2;1.213,7;161,6;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;3.954,6;2.301,4;1.289,6;363,7;
Personnel in R&D in biotechnology (FTE): women;5.385,8;3.708,1;1.422,7;254,9;
Personnel in R&D in biotechnology (FTE): (women) Researchers;3.032,9;2.267,1;681,8;84;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;2.352,9;1.441;741;170,9;
Internal expenditure on R&D (thousands of euros);940.230;640.141;263.135;36.954;
1) By nature of the expense: Current expenses;871.813;593.046;244.592;34.175;
1.1) Remuneration to researchers;284.936;194.991;82.018;7.927;
1.2) Remuneration to technicians and assistants;148.254;76.812;61.300;10.143;
1.3) Other current expenses;438.623;321.243;101.274;16.105;
2) By nature of the expense: Capital expenses;68.417;47.095;18.543;2.779;
2.1) Land and buildings;11.763;7.319;2.786;1.659;
2.2) Equipment and instruments;39.641;23.874;14.738;1.028;
2.3) Acquisition of specific R&D software;2.831;2.597;151;83;
2.4) Otros productos de propiedad intelectual específicos para I+D;14.183;13.305;868;10;
1.1) By origin of the funds: Own funds;577.287;340.644;203.482;33.161;
1.2) By origin of the funds: From companies;142.672;134.119;8.553;0;
1.3) By origin of the funds: Public Administration funds;102.630;91.765;9.516;1.350;
1.4) By origin of the funds: From Universities;457;453;5;0;
1.5) By origin of the funds: From non profit private institutions;9.631;9.631;0;0;
1.6) By origin of the funds: Foreign funds;107.553;63.529;41.580;2.444;
Purchase of R&D services in biotechnology (thousands of euros);114.839;57.515;56.730;594;
Purchase of R&D services in biotechnology (thousands of euros): In Spain;69.258;21.868;46.928;462;
Purchase of R&D services in biotechnology (thousands of euros): Abroad;45.581;35.647;9.802;132;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;41,8;51,5;24,9;25,4;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;12;10,6;13,6;17,8;
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;13,1;13,5;12,3;12,7;
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;10,7;12,6;7,6;6,1;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;15,1;18,4;8,8;12,1;
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;15,7;20,4;6,9;10,2;
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;15,9;17,2;12,9;16,1;
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;37;40;33;30;
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;50,7;55,3;40,9;51,3;
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;19;18,9;18;24,1;
% Companies that have requested biotechnology patents in Biotechnology;18,3;22,8;11,5;6;
Number of patents requested;643;513;108;22;
% Companies with income of an international origin related to biotechnological activities;24,4;27;22,1;9,5;
% Turnover representing income of an international origin related to biotechnological activities;1,6;5,8;1,3;1,6;
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;55,7;30,6;63,4;70,6;
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;44,3;69,4;36,6;29,4;
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;70,3;94,8;62;98,7;
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;23,9;0,4;31,7;1,3;
% Income of an international origin related with activities according to the classification: Operating source abroad;5,3;2,4;6,3;0;
% Income of an international origin related with activities according to the classification: Other;0,6;2,4;0;0;
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute